Large gap with delayed quotes
|
Last quote
12/15/2025
-
22:15:00
|
Bid
12/15/2025 -
22:00:00
|
Bid Volume |
Ask
12/15/2025 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
107.59
+0.59
(
+0.55% )
|
107.61
|
7,600 |
107.62
|
2,600 |
Analysis date: 12.12.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 31.10.2025.
Interest
None
None
No stars since 31.10.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 07.10.2025 at a price of 125.20.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 31.10.2025.
4wk Rel Perf
-7.16%
-7.16%
The four-week dividend-adjusted underperformance versus SP500 is 7.16%.
Sensibility
Low
Low
Low, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.52%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 1.98%.
Mkt Cap in $bn
10.75
10.75
With a market capitalization >$8bn, ENCOMPASS HEALTH is considered a large-cap stock.
G/PE Ratio
0.79
0.79
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
17.22
17.22
The estimated PE is for the year 2027.
LT Growth
12.91%
12.91%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
0.71%
0.71%
The twelve month estimated dividend yield represents 12.20% of earnings forecasts.
Beta
63
63
For 1% of index variation, the stock varies on average by 0.63%.
Correlation
0.44
0.44
44.28% of stock movements are explained by index variations.
Value at Risk
10.26
10.26
The value at risk is estimated at USD 10.26. The risk is therefore 9.59%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.12.2011
02.12.2011